Healthcare Stocks in India
46 healthcare companies (hospitals, labs, medical equipment and pharmacies) are listed in India. The biggest by market value at the 20 November 2026 close are Apollo Hospitals Enterprise, Max Healthcare Institute and Aster DM Quality Care. 10 of the 46 are beating the Nifty 500 at the 13 November 2026 scan.
Healthcare stocks listed in India, with share price
Here are all 46 healthcare companies on this list, with price, P/E (P/B for lenders), 52-week high and low and returns against the Nifty 500. The biggest by market value are Apollo Hospitals Enterprise, Max Healthcare Institute and Aster DM Quality Care. 17 of the 46 are worth less than ₹2,000 crore.
- Apollo Hospitals Enterprise: ₹9,200 on 20 Nov 2026 | market cap ₹1,32,282 cr | P/E 58.5 | ROCE 17.4%
- Max Healthcare Institute: ₹1,081 on 20 Nov 2026 | market cap ₹1,05,217 cr | P/E 74.1 | ROCE 14.7%
- Aster DM Quality Care: ₹779.3 on 20 Nov 2026 | market cap ₹67,929 cr | P/E 129.4 | ROCE 11.6%
- Fortis Healthcare: ₹825 on 20 Nov 2026 | market cap ₹62,284 cr | P/E 58.1 | ROCE 13.4%
- Global Health: ₹1,480.2 on 20 Nov 2026 | market cap ₹39,799 cr | P/E 61.5 | ROCE 17.4%
- Narayana Hrudayalaya: ₹1,943.7 on 20 Nov 2026 | market cap ₹39,721 cr | P/E 43.9 | ROCE 15.5%
- Dr Lal Pathlabs: ₹2,006 on 20 Nov 2026 | market cap ₹33,670 cr | P/E 55.6 | ROCE 28.0%
- Krishna Institute of Medical Sciences: ₹795.6 on 20 Nov 2026 | market cap ₹33,416 cr | P/E 164.6 | ROCE 9.5%
- Dr Agarwals Health Care: ₹553.4 on 20 Nov 2026 | market cap ₹17,545 cr | P/E 98.0 | ROCE 10.9%
- Poly Medicure: ₹1,635.7 on 20 Nov 2026 | market cap ₹16,580 cr | P/E 52.4 | ROCE 12.5%
| Company | Price | Market cap | P/E or P/B | 52W high / low | Earnings growth, 12 months | 3M vs Nifty 500 | 1Y vs Nifty 500 |
|---|---|---|---|---|---|---|---|
| Apollo Hospitals EnterpriseHospitals and clinics | ₹9,200 | ₹1,32,282 cr | 58.5 | ₹9,327 / ₹6,680 | +34% | −5.0 pts | +15.3 pts |
| Max Healthcare InstituteHospitals and clinicsProviding healthcare services through primary care clinics | ₹1,081 | ₹1,05,217 cr | 74.1 | ₹1,187 / ₹797 | +2% | −6.7 pts | −13.7 pts |
| Aster DM Quality CareHospitals and clinicsOne of the largest integrated private healthcare service providers operating in GCC countries | ₹779.3 | ₹67,929 cr | 129.4 | ₹891 / ₹519 | +8% | −12.7 pts | +7.0 pts |
| Fortis HealthcareHospitals and clinicsA leading integrated healthcare service provider in India | ₹825 | ₹62,284 cr | 58.1 | ₹1,010 / ₹705 | +2% | −18.4 pts | −18.1 pts |
| Global HealthHospitals and clinicsOperates a network of multi-specialty tertiary and quaternary care hospitals | ₹1,480.2 | ₹39,799 cr | 61.5 | ₹1,544 / ₹955 | +10% | +1.6 pts | +24.2 pts |
| Narayana HrudayalayaHospitals and clinicsProviding economical healthcare services | ₹1,943.7 | ₹39,721 cr | 43.9 | ₹2,094 / ₹1,564 | +2% | +0.9 pts | +6.5 pts |
| Dr Lal PathlabsDiagnostic labs | ₹2,006 | ₹33,670 cr | 55.6 | ₹2,080 / ₹1,272 | +9% | +3.4 pts | +26.8 pts |
| Krishna Institute of Medical SciencesHospitals and clinicsOffers multidisciplinary healthcare services | ₹795.6 | ₹33,416 cr | 164.6 | ₹858 / ₹576 | -38% | −10.4 pts | +10.2 pts |
| Dr Agarwals Health CareHospitals and clinicsOffers a wide array of eye care services | ₹553.4 | ₹17,545 cr | 98.0 | ₹572 / ₹401 | +49% | +8.2 pts | +5.6 pts |
| Poly MedicureMedical equipmentAn India-based manufacturer and exporter of medical devices | ₹1,635.7 | ₹16,580 cr | 52.4 | ₹2,024 / ₹1,182 | -12% | −6.5 pts | −13.1 pts |
| Vijaya Diagnostic CentreDiagnostic labsOffers comprehensive services that include nuclear medicine, radiology, laboratory, health check-ups and medical services | ₹1,572.3 | ₹16,195 cr | 79.5 | ₹1,594 / ₹848 | +34% | −4.9 pts | +33.4 pts |
| Rainbow Childrens MedicareHospitals and clinicsOperates a multi-specialty pediatric, obstetrics, and gynecology hospital chain in India | ₹1,259.7 | ₹12,794 cr | 43.6 | ₹1,610 / ₹1,009 | +15% | −13.6 pts | −4.8 pts |
| Metropolis HealthcareDiagnostic labsOwns a chain of diagnostic centres across India, South Asia | ₹566 | ₹11,746 cr | 50.9 | ₹609 / ₹412 | +41% | +2.8 pts | +14.9 pts |
| Yatharth Hospital & Trauma Care ServicesHospitals and clinics | ₹1,093.25 | ₹10,534 cr | 55.2 | ₹1,184 / ₹538 | +25% | +25.0 pts | +33.9 pts |
| Jupiter Life Line HospitalsHospitals and clinicsA multi-specialty tertiary and quaternary healthcare provider in the Mumbai Metropolitan Area and western | ₹317.4 | ₹10,406 cr | 54.8 | ₹340 / ₹230 | -6% | −10.4 pts | −2.3 pts |
| Park Medi WorldHospitals and clinics | ₹238.05 | ₹10,282 cr | 40.1 | ₹305 / ₹138 | +3% | −9.8 pts | |
| Healthcare Global EnterprisesHospitals and clinicsSetting up and managing hospitals and medical diagnostic services | ₹624.95 | ₹9,330 cr | 234.5 | ₹775 / ₹513 | -71% | −20.4 pts | −21.7 pts |
| Thyrocare TechnologiesDiagnostic labs | ₹528.45 | ₹8,421 cr | 48.0 | ₹662 / ₹343 | +13% | −20.8 pts | −4.0 pts |
| Entero Healthcare SolutionsPharmacies and medicine distributors | ₹1,901.8 | ₹8,286 cr | 58.0 | ₹2,138 / ₹944 | +26% | +38.4 pts | +76.0 pts |
| Medplus Health ServicesPharmacies and medicine distributors | ₹603.95 | ₹7,257 cr | 34.3 | ₹1,022 / ₹566 | +8% | −8.0 pts | −20.3 pts |
| Kovai Medical Center & HospitalHospitals and clinics | ₹6,581 | ₹7,200 cr | 26.3 | ₹6,750 / ₹5,010 | +20% | +8.1 pts | +9.7 pts |
| Nephrocare Health ServicesHospitals and clinicsProvides end-to-end dialysis care through a wide network of clinics across India and select | ₹655.8 | ₹6,595 cr | 51.5 | ₹782 / ₹445 | -75% | −7.1 pts | |
| Artemis Medicare ServicesHospitals and clinicsOperates a 541-bedded multi-specialty tertiary care hospital in Gurgaon | ₹340.8 | ₹5,395 cr | 46.1 | ₹379 / ₹203 | +6% | +1.7 pts | +20.1 pts |
| Zota Health CarePharmacies and medicine distributorsManufactures, markets, and exports pharmaceutical, ayurvedic, nutraceutical | ₹1,288 | ₹4,460 cr | Loss | ₹1,740 / ₹1,022 | +14.1 pts | −18.4 pts | |
| Indraprastha Medical CorporationHospitals and clinics | ₹362.6 | ₹3,325 cr | 17.4 | ₹553 / ₹294 | +10% | −12.2 pts | −39.3 pts |
| KMC Speciality HospitalsHospitals and clinicsRendering medical and healthcare services | ₹203.78 | ₹3,323 cr | 54.4 | ₹203.78 / ₹70.5 | +102% | +25.8 pts | +113.2 pts |
| Dr Agarwals Eye HospitalHospitals and clinics | ₹6,088 | ₹2,942 cr | 38.6 | ₹6,392 / ₹4,412 | +28% | +12.1 pts | +16.4 pts |
| Sakar HealthcareHospitals and clinics | ₹1,023.4 | ₹2,277 cr | 53.1 | ₹1,230 / ₹352 | +118% | +18.4 pts | +164.4 pts |
| Vimta LabsDiagnostic labsA contract research and testing services provider | ₹467.65 | ₹2,090 cr | 25.7 | ₹675 / ₹376 | +2% | −19.7 pts | −21.5 pts |
| Krsnaa DiagnosticsDiagnostic labsProvides a range of technology-enabled diagnostic services such as imaging, clinical laboratory | ₹519.05 | ₹1,684 cr | 17.2 | ₹839 / ₹462 | +16% | −8.7 pts | −34.0 pts |
| Suraksha DiagnosticDiagnostic labsOffers an integrated pathology, radiology testing, and medical consultancy services solution | ₹311.5 | ₹1,623 cr | 38.8 | ₹384 / ₹224 | +31% | +11.5 pts | +10.6 pts |
| Tarsons ProductsMedical equipmentDesigning, development, manufacturing, and marketing of 'consumables', 'reusables' and 'others' | ₹303.4 | ₹1,614 cr | 197.2 | ₹375 / ₹164 | -63% | −13.0 pts | +32.0 pts |
| ShalbyHospitals and clinicsHealthcare delivery space in India | ₹122.15 | ₹1,319 cr | 33.7 | ₹228 / ₹111 | 4 times or more | −19.5 pts | −44.4 pts |
| Gujarat Kidney & Super SpecialityHospitals and clinics | ₹149.28 | ₹1,177 cr | 61.9 | ₹210 / ₹98.2 | +21% | +13.5 pts | |
| 3B Blackbio DXDiagnostic labsManufactures and exports PCR based Molecular Diagnostic kits, PCR Enzymes & PCR Reagents | ₹1,305.1 | ₹1,120 cr | 19.1 | ₹1,750 / ₹1,084 | +19% | +13.6 pts | −3.2 pts |
| GPT HealthcareHospitals and clinicsRunning hospitals and providing medical services | ₹133.98 | ₹1,099 cr | 21.1 | ₹175 / ₹114 | +20% | −8.5 pts | +1.0 pts |
| Laxmi DentalMedical equipmentAn integrated dental products company offering a comprehensive portfolio of Dental Products | ₹187.57 | ₹1,033 cr | 28.4 | ₹315 / ₹156 | +23% | +0.5 pts | −34.0 pts |
| Health X PlatformPharmacies and medicine distributors | ₹275.6 | ₹876 cr | Loss | ₹375 / ₹252 | −6.4 pts | −4.0 pts | |
| Sastasundar VenturesPharmacies and medicine distributors | ₹874 cr | 34.9 | −0.6 pts | −3.4 pts | |||
| Hemant Surgical IndustriesMedical equipment | ₹590.3 | ₹858 cr | 49.2 | ₹679 / ₹215 | +80% | +74.3 pts | +120.6 pts |
| Unihealth HospitalsHospitals and clinics | ₹492.1 | ₹844 cr | 32.9 | ₹820 / ₹179 | −21.5 pts | +225.8 pts | |
| Vasa DenticityMedical equipment | ₹451.5 | ₹789 cr | 65.7 | ₹612 / ₹322 | -26% | +15.6 pts | −18.0 pts |
| One Global Service ProviderDiagnostic labs | ₹373.05 | ₹729 cr | 11.6 | ₹790 / ₹327 | -28% | −33.7 pts | −4.7 pts |
| Gaudium IVF and Women HealthHospitals and clinicsIn Vitro Fertilization treatments throughout India | ₹99.57 | ₹725 cr | 31.2 | ₹164 / ₹69.2 | -10% | −14.5 pts | |
| Chandan HealthcareDiagnostic labsRuns diagnostic centers in North India with pathology and radiology testing services | ₹240 | ₹587 cr | 22.3 | ₹358 / ₹185 | −5.6 pts | −24.4 pts | |
| Prevest DenproMedical equipment | ₹369.3 | ₹443 cr | 20.4 | ₹514 / ₹318 | +15% | +8.9 pts | −13.1 pts |
Download all 46 (CSV). "Earnings growth" is earnings per share over the last 12 months against the 12 months before. "vs Nifty 500" is the stock's return minus the Nifty 500's, in percentage points.
Prices and market value as of 20 November 2026. Earnings growth and returns from the weekly scan to 13 November 2026. Updated every weekend
Key factors for healthcare stocks
10 of the 46 healthcare stocks here beat the Nifty 500 over 3 months to 13 November 2026. Four weeks earlier it was 12. The lines below give this list's own numbers.
- Earnings: 32 of the 41 with results have earnings per share higher than a year earlier
- Price against its own history: 23 of the 44 with a long P/E record trade above their own usual P/E at the 20 November 2026 price
- Debt: 32 of the 46 non-lenders owe less than half their shareholders' money (debt to equity under 0.5)
These describe the group, not any one company. Each company's own numbers are in the table above.
46 companies on this page. Prices and ratios as of 20 November 2026, returns from the weekly scan to 13 November 2026, results from the latest quarter
What are healthcare stocks?
Healthcare stocks are shares of companies that run hospitals and clinics, test samples in labs, make medical equipment, or distribute medicines and run pharmacies. The 46 on this page fall into 4 groups. The biggest group is hospitals and clinics, with 25 companies.
| Group | Companies | Beating Nifty 500 | Biggest |
|---|---|---|---|
| Hospitals and clinics | 25 | 6 of 25 | Apollo Hospitals Enterprise, Max Healthcare Institute, Aster DM Quality Care |
| Diagnostic labs | 10 | 1 of 10 | Dr Lal Pathlabs, Vijaya Diagnostic Centre, Metropolis Healthcare |
| Medical equipment | 6 | 2 of 6 | Poly Medicure, Tarsons Products, Laxmi Dental |
| Pharmacies and medicine distributors | 5 | 1 of 5 | Entero Healthcare Solutions, Medplus Health Services, Zota Health Care |
The rule in one line: a company is here when its main business is running hospitals or clinics, testing samples in labs, making medical equipment, or distributing medicines and running pharmacies. NSE's hospital, diagnostics, medical equipment and pharmacy industries are the list. Companies that make medicines are on the pharma stocks list instead.
Left out on purpose
- Companies that make medicines (formulations, drug ingredients, contract manufacturing) are on the pharma stocks list, not here.
- Health insurers offer insurance, not care, so they are not on this list.
Membership checked every month. Industries follow NSE industry groups
Why are healthcare stocks rising or falling?
23 of the 44 healthcare stocks with a P/E history traded above their own usual P/E (P/E at the 20 November 2026 price). Among the 10 biggest, earnings per share fell over 12 months at Krishna Institute of Medical Sciences (-38%) and Poly Medicure (-12%). 26 of the 46 are behind the Nifty 500 over the last 3 months. The furthest behind are One Global Service Provider (−33.7 points) and Unihealth Hospitals (−21.5 points).
What the industry research says is going wrong
- The main risks are expansion costs arriving before patients, overdue government payments, temporary government-scheme pricing benefits, specialty adoption taking longer, and changed management disclosures.
- Conflicting member-participation measures also weaken confidence in the sector-wide price signal.
The 10 furthest behind the Nifty 500
- One Global Service Provider −33.7 points against the Nifty 500 in 3 months. Earnings per share fell 28% in the last 12 months.
- Unihealth Hospitals −21.5 points against the Nifty 500 in 3 months. Next to check, from the September 2026 call: nashik inpatient build-up from November.
- Thyrocare Technologies −20.8 points against the Nifty 500 in 3 months. Earnings per share up 13% in the last 12 months. Watch: The specialty timetable widened after earlier radiology and Tanzania expectations were not delivered as first framed.
- Healthcare Global Enterprises −20.4 points against the Nifty 500 in 3 months. Earnings per share fell 71% in the last 12 months.
- Vimta Labs −19.7 points against the Nifty 500 in 3 months. Earnings per share up 2% in the last 12 months. Next to check, from the October 2026 call: food sample flows returning to earlier volumes on export-import recovery.
- Shalby −19.5 points against the Nifty 500 in 3 months. Earnings per share grew 4 times or more in the last 12 months. Next to check, from the November 2026 call: gurugram cash breakeven arrival at flagged quarter-end.
- Fortis Healthcare −18.4 points against the Nifty 500 in 3 months. Earnings per share up 2% in the last 12 months.
- Gaudium IVF and Women Health −14.5 points against the Nifty 500 in 3 months. Earnings per share fell 10% in the last 12 months. Next to check, from the November 2026 call: nagpur hub to move from ready-awaiting-approval to operational.
- Rainbow Childrens Medicare −13.6 points against the Nifty 500 in 3 months. Earnings per share up 15% in the last 12 months.
- Tarsons Products −13.0 points against the Nifty 500 in 3 months. Earnings per share fell 63% in the last 12 months. Next to check, from the November 2026 call: standalone export growth holding strongly double-digit next quarter despite container curbs.
This page does not track prices during the day. For today's moves, see the exchange.
Weekly data to 13 November 2026. Reasons from company calls and the industry research, refreshed every month
How is each healthcare stock valued against its own history?
23 of the 44 healthcare stocks with a P/E history trade above their own usual P/E (P/B for lenders), and 21 below. The furthest below their own history are Krsnaa Diagnostics (-40%), Prevest Denpro (-36%) and Nephrocare Health Services (-35%).
Show the table
| Company | Measure | Now | Usual | Gap | Earnings growth, 12 months |
|---|---|---|---|---|---|
| Medplus Health ServicesP/ | P/E | 34.3 | 137.6 | -75% | +8% |
| Krsnaa DiagnosticsP/ | P/E | 17.2 | 28.8 | -40% | +16% |
| Prevest DenproP/ | P/E | 20.4 | 32.0 | -36% | +15% |
| Nephrocare Health ServicesP/ | P/E | 51.5 | 78.9 | -35% | -75% |
| Laxmi DentalP/ | P/E | 28.4 | 38.7 | -27% | +23% |
| Gujarat Kidney & Super SpecialityP/ | P/E | 61.9 | 83.6 | -26% | +21% |
| GPT HealthcareP/ | P/E | 21.1 | 27.3 | -23% | +20% |
| Dr Agarwals Health CareP/ | P/E | 98.0 | 126.1 | -22% | +49% |
| Apollo Hospitals EnterpriseP/ | P/E | 58.5 | 74.2 | -21% | +34% |
| One Global Service ProviderP/ | P/E | 11.6 | 14.8 | -21% | -28% |
| Suraksha DiagnosticP/ | P/E | 38.8 | 47.0 | -17% | +31% |
| Rainbow Childrens MedicareP/ | P/E | 43.6 | 51.4 | -15% | +15% |
| Gaudium IVF and Women HealthP/ | P/E | 31.2 | 36.7 | -15% | -10% |
| Metropolis HealthcareP/ | P/E | 50.9 | 58.4 | -13% | +41% |
| ShalbyP/ | P/E | 33.7 | 37.3 | -10% | 4 times or more |
| Fortis HealthcareP/ | P/E | 58.1 | 62.0 | -6% | +2% |
| Narayana HrudayalayaP/ | P/E | 43.9 | 46.8 | -6% | +2% |
| Chandan HealthcareP/ | P/E | 22.3 | 23.6 | -6% | |
| Global HealthP/ | P/E | 61.5 | 63.3 | -3% | +10% |
| Vimta LabsP/ | P/E | 25.7 | 26.2 | -2% | +2% |
| Indraprastha Medical CorporationP/ | P/E | 17.4 | 17.5 | -1% | +10% |
| Dr Lal PathlabsP/ | P/E | 55.6 | 55.5 | 0% | +9% |
| Thyrocare TechnologiesP/ | P/E | 48.0 | 47.9 | 0% | +13% |
| Max Healthcare InstituteP/ | P/E | 74.1 | 73.4 | +1% | +2% |
| Entero Healthcare SolutionsP/ | P/E | 58.0 | 56.6 | +2% | +26% |
| 3B Blackbio DXP/ | P/E | 19.1 | 18.4 | +4% | +19% |
| Vasa DenticityP/ | P/E | 65.7 | 62.6 | +5% | -26% |
| Park Medi WorldP/ | P/E | 40.1 | 37.1 | +8% | +3% |
| Jupiter Life Line HospitalsP/ | P/E | 54.8 | 50.5 | +9% | -6% |
| Poly MedicureP/ | P/E | 52.4 | 44.9 | +17% | -12% |
| Vijaya Diagnostic CentreP/ | P/E | 79.5 | 66.6 | +19% | +34% |
| Artemis Medicare ServicesP/ | P/E | 46.1 | 38.7 | +19% | +6% |
| Yatharth Hospital & Trauma Care ServicesP/ | P/E | 55.2 | 45.2 | +22% | +25% |
| KMC Speciality HospitalsP/ | P/E | 54.4 | 42.8 | +27% | +102% |
| Dr Agarwals Eye HospitalP/ | P/E | 38.6 | 30.4 | +27% | +28% |
| Unihealth HospitalsP/ | P/E | 32.9 | 25.1 | +31% | |
| Sakar HealthcareP/ | P/E | 53.1 | 39.8 | +33% | +118% |
| Kovai Medical Center & HospitalP/ | P/E | 26.3 | 19.7 | +34% | +20% |
| Sastasundar VenturesP/ | P/E | 34.9 | 24.1 | +45% | |
| Hemant Surgical IndustriesP/ | P/E | 49.2 | 32.7 | +50% | +80% |
| Healthcare Global EnterprisesP/ | P/E | 234.5 | 148.5 | +58% | -71% |
| Aster DM Quality CareP/ | P/E | 129.4 | 39.8 | +225% | +8% |
| Krishna Institute of Medical SciencesP/ | P/E | 164.6 | 48.8 | +238% | -38% |
| Tarsons ProductsP/ | P/E | 197.2 | 50.3 | +292% | -63% |
"Usual" = each company's own long-run median. Now = at the 20 November 2026 price, usual from our weekly valuation record, no price targets
Which healthcare stocks are in the Nifty indices?
NSE's Nifty Healthcare index has 20 companies. 4 of them are on this list. Abbott India, Alkem Laboratories, Aurobindo Pharma, Biocon, Cipla, Divis Laboratories, Dr Reddys Laboratories, Gland Pharma, Glenmark Pharmaceuticals, Ipca Laboratories, Laurus Labs, Lupin, Mankind Pharma, Sun Pharmaceutical Industries, Torrent Pharmaceuticals and Zydus Lifesciences are left out. This list has 42 more companies that the index does not hold.
Show the table
| Company | NSE sector | On this list | Price | Market cap | 3M vs Nifty 500 |
|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | Healthcare | No | ₹1,884.9 | ₹4,52,251 cr | −3.2 pts |
| Divis Laboratories | Healthcare | No | ₹11,180.5 | ₹2,96,807 cr | +34.4 pts |
| Torrent Pharmaceuticals | Healthcare | No | ₹4,689.5 | ₹1,78,374 cr | −4.0 pts |
| Apollo Hospitals Enterprise | Healthcare | Yes | ₹9,200 | ₹1,32,282 cr | −5.0 pts |
| Laurus Labs | Healthcare | No | ₹2,294.6 | ₹1,23,980 cr | +35.0 pts |
| Zydus Lifesciences | Healthcare | No | ₹1,200 | ₹1,19,700 cr | +4.2 pts |
| Dr Reddys Laboratories | Healthcare | No | ₹1,390.2 | ₹1,16,119 cr | +14.4 pts |
| Cipla | Healthcare | No | ₹1,415 | ₹1,14,316 cr | −4.6 pts |
| Mankind Pharma | Healthcare | No | ₹2,665 | ₹1,10,077 cr | +8.3 pts |
| Max Healthcare Institute | Healthcare | Yes | ₹1,081 | ₹1,05,217 cr | −6.7 pts |
| Aurobindo Pharma | Healthcare | No | ₹1,799 | ₹1,03,511 cr | +11.8 pts |
| Lupin | Healthcare | No | ₹2,014 | ₹92,099 cr | −12.0 pts |
| Glenmark Pharmaceuticals | Healthcare | No | ₹2,648 | ₹74,733 cr | +13.3 pts |
| Fortis Healthcare | Healthcare | Yes | ₹825 | ₹62,284 cr | −18.4 pts |
| Alkem Laboratories | Healthcare | No | ₹5,185 | ₹61,995 cr | −5.3 pts |
| Biocon | Healthcare | No | ₹364.4 | ₹59,386 cr | −13.3 pts |
| Abbott India | Healthcare | No | ₹26,525 | ₹56,366 cr | −2.9 pts |
| Gland Pharma | Healthcare | No | ₹3,331.9 | ₹54,980 cr | +11.7 pts |
| Ipca Laboratories | Healthcare | No | ₹1,843.8 | ₹46,778 cr | +8.1 pts |
| Krishna Institute of Medical Sciences | Healthcare | Yes | ₹795.6 | ₹33,416 cr | −10.4 pts |
Abbott India is in the index but not on this list because it makes medicines, so it is on the pharma stocks list instead. Alkem Laboratories is in the index but not on this list because it makes medicines, so it is on the pharma stocks list instead. Aurobindo Pharma is in the index but not on this list because it makes medicines, so it is on the pharma stocks list instead. Biocon is in the index but not on this list because it makes medicines, so it is on the pharma stocks list instead. Cipla is in the index but not on this list because it makes medicines, so it is on the pharma stocks list instead. Divis Laboratories is in the index but not on this list because it makes medicines, so it is on the pharma stocks list instead. Dr Reddys Laboratories is in the index but not on this list because it makes medicines, so it is on the pharma stocks list instead. Gland Pharma is in the index but not on this list because it makes medicines, so it is on the pharma stocks list instead. Glenmark Pharmaceuticals is in the index but not on this list because it makes medicines, so it is on the pharma stocks list instead. Ipca Laboratories is in the index but not on this list because it makes medicines, so it is on the pharma stocks list instead. Laurus Labs is in the index but not on this list because it makes medicines, so it is on the pharma stocks list instead. Lupin is in the index but not on this list because it makes medicines, so it is on the pharma stocks list instead. Mankind Pharma is in the index but not on this list because it makes medicines, so it is on the pharma stocks list instead. Sun Pharmaceutical Industries is in the index but not on this list because it makes medicines, so it is on the pharma stocks list instead. Torrent Pharmaceuticals is in the index but not on this list because it makes medicines, so it is on the pharma stocks list instead. Zydus Lifesciences is in the index but not on this list because it makes medicines, so it is on the pharma stocks list instead.
NSE's own member file, read on 17 October 2026. Checked every week
Small cap healthcare stocks and share prices
1 of the 46 healthcare stocks trade under ₹100 a share: Gaudium IVF and Women Health (₹99.57). By size, 1 is large cap, 5 are mid cap and 40 are small cap.
Show the table
Healthcare stocks under ₹100
| Company | Price | Market cap | Earnings growth, 12 months | Debt to equity |
|---|---|---|---|---|
| Gaudium IVF and Women Health | ₹99.57 | ₹725 cr | -10% | 0.14 |
A low share price says nothing about how big the company is. Market cap shows the size.
Large cap healthcare stocks (1)
| Company | Market cap | Price | Beating Nifty 500 |
|---|---|---|---|
| Apollo Hospitals Enterprise | ₹1,32,282 cr | ₹9,200 | No |
Mid cap healthcare stocks (5)
| Company | Market cap | Price | Beating Nifty 500 |
|---|---|---|---|
| Max Healthcare Institute | ₹1,05,217 cr | ₹1,081 | No |
| Aster DM Quality Care | ₹67,929 cr | ₹779.3 | No |
| Fortis Healthcare | ₹62,284 cr | ₹825 | No |
| Global Health | ₹39,799 cr | ₹1,480.2 | No |
| Narayana Hrudayalaya | ₹39,721 cr | ₹1,943.7 | No |
Small cap healthcare stocks (40)
| Company | Market cap | Price | Beating Nifty 500 |
|---|---|---|---|
| Dr Lal Pathlabs | ₹33,670 cr | ₹2,006 | No |
| Krishna Institute of Medical Sciences | ₹33,416 cr | ₹795.6 | No |
| Dr Agarwals Health Care | ₹17,545 cr | ₹553.4 | Yes |
| Poly Medicure | ₹16,580 cr | ₹1,635.7 | No |
| Vijaya Diagnostic Centre | ₹16,195 cr | ₹1,572.3 | No |
| Rainbow Childrens Medicare | ₹12,794 cr | ₹1,259.7 | No |
| Metropolis Healthcare | ₹11,746 cr | ₹566 | No |
| Yatharth Hospital & Trauma Care Services | ₹10,534 cr | ₹1,093.25 | Yes |
| Jupiter Life Line Hospitals | ₹10,406 cr | ₹317.4 | No |
| Park Medi World | ₹10,282 cr | ₹238.05 | No |
| Healthcare Global Enterprises | ₹9,330 cr | ₹624.95 | No |
| Thyrocare Technologies | ₹8,421 cr | ₹528.45 | No |
| Entero Healthcare Solutions | ₹8,286 cr | ₹1,901.8 | Yes |
| Medplus Health Services | ₹7,257 cr | ₹603.95 | No |
| Kovai Medical Center & Hospital | ₹7,200 cr | ₹6,581 | Yes |
| Nephrocare Health Services | ₹6,595 cr | ₹655.8 | No |
| Artemis Medicare Services | ₹5,395 cr | ₹340.8 | No |
| Zota Health Care | ₹4,460 cr | ₹1,288 | No |
| Indraprastha Medical Corporation | ₹3,325 cr | ₹362.6 | No |
| KMC Speciality Hospitals | ₹3,323 cr | ₹203.78 | Yes |
| Dr Agarwals Eye Hospital | ₹2,942 cr | ₹6,088 | Yes |
| Sakar Healthcare | ₹2,277 cr | ₹1,023.4 | Yes |
| Vimta Labs | ₹2,090 cr | ₹467.65 | No |
| Krsnaa Diagnostics | ₹1,684 cr | ₹519.05 | No |
| Suraksha Diagnostic | ₹1,623 cr | ₹311.5 | Yes |
| Tarsons Products | ₹1,614 cr | ₹303.4 | No |
| Shalby | ₹1,319 cr | ₹122.15 | No |
| Gujarat Kidney & Super Speciality | ₹1,177 cr | ₹149.28 | No |
| 3B Blackbio DX | ₹1,120 cr | ₹1,305.1 | No |
| GPT Healthcare | ₹1,099 cr | ₹133.98 | No |
| Laxmi Dental | ₹1,033 cr | ₹187.57 | No |
| Health X Platform | ₹876 cr | ₹275.6 | No |
| Sastasundar Ventures | ₹874 cr | No | |
| Hemant Surgical Industries | ₹858 cr | ₹590.3 | Yes |
| Unihealth Hospitals | ₹844 cr | ₹492.1 | No |
| Vasa Denticity | ₹789 cr | ₹451.5 | No |
| One Global Service Provider | ₹729 cr | ₹373.05 | No |
| Gaudium IVF and Women Health | ₹725 cr | ₹99.57 | No |
| Chandan Healthcare | ₹587 cr | ₹240 | No |
| Prevest Denpro | ₹443 cr | ₹369.3 | Yes |
Size = rank by market value across every company we score: the top 100 are large cap, the next 150 mid cap, the rest small cap. Updated every weekend
Which healthcare stocks pay dividends?
The highest dividend yields among healthcare stocks are GPT Healthcare (1.9%), Thyrocare Technologies (1.8%) and Indraprastha Medical Corporation (1.1%). 26 of the 46 paid a dividend in the last year.
Show the table
| Company | Dividend yield | Price | Market cap |
|---|---|---|---|
| GPT Healthcare | 1.9% | ₹133.98 | ₹1,099 cr |
| Thyrocare Technologies | 1.8% | ₹528.45 | ₹8,421 cr |
| Indraprastha Medical Corporation | 1.1% | ₹362.6 | ₹3,325 cr |
| Dr Lal Pathlabs | 0.7% | ₹2,006 | ₹33,670 cr |
| Vimta Labs | 0.4% | ₹467.65 | ₹2,090 cr |
| Aster DM Quality Care | 0.4% | ₹779.3 | ₹67,929 cr |
| Krsnaa Diagnostics | 0.4% | ₹519.05 | ₹1,684 cr |
| 3B Blackbio DX | 0.4% | ₹1,305.1 | ₹1,120 cr |
| Metropolis Healthcare | 0.3% | ₹566 | ₹11,746 cr |
| Rainbow Childrens Medicare | 0.3% | ₹1,259.7 | ₹12,794 cr |
| Prevest Denpro | 0.3% | ₹369.3 | ₹443 cr |
| One Global Service Provider | 0.3% | ₹373.05 | ₹729 cr |
| Narayana Hrudayalaya | 0.2% | ₹1,943.7 | ₹39,721 cr |
| Kovai Medical Center & Hospital | 0.2% | ₹6,581 | ₹7,200 cr |
| Poly Medicure | 0.2% | ₹1,635.7 | ₹16,580 cr |
Yield = last year's dividend divided by today's price. It moves with the price. Updated every weekend
Latest results calls from healthcare companies
37 of the 46 healthcare companies have a results call on record since June 2026. The latest were Health X Platform (16 November), Gaudium IVF and Women Health (16 November) and Park Medi World (14 November). The lines below are our short summary of each call, not the company's words.
- Health X Platform results call, 16 November 2026
Tone: cautiously optimistic. Rapid growth with expanding gross and falling cost ratio, yet loss persists as new-market hiring runs ahead of revenue.
- Gaudium IVF and Women Health results call, 16 November 2026
Tone: positive. Next to check: Nagpur hub to move from ready-awaiting-approval to operational.
- Suraksha Diagnostic results call, 13 November 2026
Tone: positive. Strong double-digit growth, Jharkhand entry and maturing centres support confidence into second half despite seasonal third quarter softness.
- Tarsons Products results call, 13 November 2026
Tone: cautiously optimistic. Second straight quarter above 20% growth with the year to March 2027 momentum retained despite input volatility and new plant drag.
- Vasa Denticity results call, 11 November 2026
Tone: cautiously optimistic. Next to check: Top-2,500 stock-outs to fall below flagged ceiling on promised path.
- Aster DM Quality Care results call, 6 November 2026
Tone: positive. Next to check: Synergy pace progression toward flagged full potential next quarter.
- Fortis Healthcare results call, 6 November 2026
Tone: cautiously optimistic. Hospital and diagnostics delivered healthy growth with occupancy and specialty momentum despite flattish margin forecast for the year.
- Apollo Hospitals Enterprise results call, 5 November 2026
Tone: positive. All three verticals delivered double-digit growth with occupancy gains and digital turning cash positive.
- Krishna Institute of Medical Sciences results call, 5 November 2026
Tone: positive. Next to check: Kondapur follow-on bed start-up with margin move toward flagged recovery.
- Poly Medicure results call, 5 November 2026
Tone: positive. Domestic strength, Europe snapback and raised standalone margin framework underpin confident tone on meeting annual ranges.
- Entero Healthcare Solutions results call, 5 November 2026
Tone: positive. Next to check: Organic outperformance to persist as calendarisation fades in coming quarters.
- Gujarat Kidney & Super Speciality results call, 5 November 2026
Tone: cautiously optimistic. Next to check: Year-end margin averaging around flagged level.
From results calls, latest 16 November 2026. Checked every weekend
What is changing for healthcare companies?
From the industry research of 10 October 2026: Total profit growth is mainly coming from higher revenue, while fuller use of established facilities helps some companies spread their costs. Hospitals and Medical Equipment were not in that run, so they have no research here yet.
Diagnostics
What is changing: Total profit growth is mainly coming from higher revenue, while fuller use of established facilities helps some companies spread their costs. This is lasting business progress, but new-project costs mean margins are not improving uniformly.
What is already happening: More testing through existing facilities is spreading fixed costs over more revenue. Leading chains are widening their reach through labs, hubs, collection centres and government projects.
Risks: The main risks are expansion costs arriving before patients, overdue government payments, temporary government-scheme pricing benefits, specialty adoption taking longer, and changed management disclosures. Conflicting member-participation measures also weaken confidence in the sector-wide price signal.
What to watch next:
- Vijaya's accreditation, hub rollout and higher capital-spending plan.
Pharmacy Distribution
What is changing: Entero is improving procurement, higher-margin medical-equipment sales and customer spending. The change is company-specific rather than uniform.
Where big money is moving: Combined foreign and domestic institutional ownership changed by +0.1 percentage points over two quarters and -1.1 points over four quarters.
What to watch next:
- Medplus's next results: own-brand mix recovery and operating-margin improvement after discount and labor-cost changes.
- Price and relative strength breaking above their existing sideways ranges.
Industry research of 10 October 2026, refreshed every two weeks
Top healthcare stocks in India (November 2026)
The top 10 healthcare stocks for November 2026 are: 1. KMC Speciality Hospitals, 2. Entero Healthcare Solutions, 3. Kovai Medical Center & Hospital, 4. Apollo Hospitals Enterprise, 5. Sakar Healthcare, 6. Metropolis Healthcare, 7. Global Health, 8. Artemis Medicare Services, 9. Yatharth Hospital & Trauma Care Services, 10. Dr Agarwals Health Care. Companies worth ₹2,000 crore or more are scored every month.
Show the list
- 1KMC Speciality Hospitals75scoreGrowth 89 · Quality 90 · Valuation 42 · Price strength 63 · vs October 2026 same
- 2Entero Healthcare Solutions69scoreGrowth 71 · Quality 57 · Valuation 50 · Price strength 100 · vs October 2026 same
- 3Kovai Medical Center & Hospital69scoreGrowth 66 · Quality 82 · Valuation 46 · Price strength 82 · vs October 2026 up 6
- 4Apollo Hospitals Enterprise68scoreGrowth 79 · Quality 67 · Valuation 60 · Price strength 57 · vs October 2026 down 1
- 5Sakar Healthcare67scoreGrowth 92 · Quality 44 · Valuation 44 · Price strength 76 · vs October 2026 down 1
- 6Metropolis Healthcare67scoreGrowth 82 · Quality 55 · Valuation 55 · Price strength 70 · vs October 2026 new
- 7Global Health65scoreGrowth 59 · Quality 75 · Valuation 45 · Price strength 85 · vs October 2026 new
- 8Artemis Medicare Services61scoreGrowth 60 · Quality 49 · Valuation 62 · Price strength 77 · vs October 2026 new
- 9Yatharth Hospital & Trauma Care Services59scoreGrowth 60 · Quality 50 · Valuation 34 · Price strength 96 · vs October 2026 down 2
- 10Dr Agarwals Health Care59scoreGrowth 82 · Quality 37 · Valuation 43 · Price strength 63 · vs October 2026 same
Why each one made the top 10
- KMC Speciality Hospitals: Score 75 of 100. Earnings per share up 102% in the last 12 months. 25.8 points ahead of the Nifty 500 over 3 months.
- Entero Healthcare Solutions: Score 69 of 100. Earnings per share up 26% in the last 12 months. 38.4 points ahead of the Nifty 500 over 3 months. Gross margin rose from 9.9% to 11.4% and sales grew faster than the medicine market. Watch: Cash was ₹96 crore against ₹146 crore of profit, with borrowings at ₹677 crore.
- Kovai Medical Center & Hospital: Score 69 of 100. Earnings per share up 20% in the last 12 months. 8.1 points ahead of the Nifty 500 over 3 months. Watch: Revenue and operational infrastructure are concentrated in Coimbatore, exposing cash flow to regional events.
- Apollo Hospitals Enterprise: Score 68 of 100. Earnings per share up 34% in the last 12 months. Revenue and reported profit rose in the latest quarter, with operating margin above the prior-year level. Watch: Gurgaon has moved from an earlier operationalization date to the fourth quarter of the fiscal year.
- Sakar Healthcare: Score 67 of 100. Earnings per share up 118% in the last 12 months. 18.4 points ahead of the Nifty 500 over 3 months.
- Metropolis Healthcare: Score 67 of 100. Earnings per share up 41% in the last 12 months. 2.8 points ahead of the Nifty 500 over 3 months.
- Global Health: Score 65 of 100. Earnings per share up 10% in the last 12 months. 1.6 points ahead of the Nifty 500 over 3 months. Reported operating margin compression to 22.0% is transient startup dilution from the 550-bed Noida facility rather than pricing or volume decay. Watch: Planned 4,850 Cr capital outlay and 800-900 Cr the year to March 2027 capex keeps free cash flow negative during construction.
- Artemis Medicare Services: Score 61 of 100. Earnings per share up 6% in the last 12 months. 1.7 points ahead of the Nifty 500 over 3 months. Next to check, from the November 2026 call: raipur occupancy reaching flagged build-up level in coming quarters.
- Yatharth Hospital & Trauma Care Services: Score 59 of 100. Earnings per share up 25% in the last 12 months. 25.0 points ahead of the Nifty 500 over 3 months. Revenue rose 28% to 52% every quarter and group operating profit reached ₹92 crore. Watch: New Delhi and Faridabad hospitals lost ₹10 crore together in December 2025.
- Dr Agarwals Health Care: Score 59 of 100. Earnings per share up 49% in the last 12 months. 8.2 points ahead of the Nifty 500 over 3 months. The latest quarter extended the revenue and profit trend while reported operating margin remained near the recent range. Watch: Rapid facility additions can depress returns before cohorts mature.
Left the top 10 since October 2026: Vijaya Diagnostic Centre, Dr Agarwals Eye Hospital, Dr Lal Pathlabs. See the November 2026 top 10 · See the October 2026 top 10.
How this top 10 is ranked
Every healthcare company on this list worth ₹2,000 crore or more is ranked (29 of 46). When two scores tie, the one with more price strength ranks higher. Each gets a score out of 100. Growth in sales and profit counts 35%. Business quality counts 25%. Valuation against growth and against the company's own history counts 20%. Price strength counts 20%. Each part is scored against companies in the same industry. This ranks past data and is not a recommendation.
Ranked on November 2026 data, refreshed every month
Which healthcare stocks are beating the Nifty 500 now?
This page uses weekly closes, not live prices. In the week to 13 November, 25 of the 34 healthcare stocks with a clean price record closed higher and 8 closed lower, and 1 closed flat. The biggest weekly gains were Krsnaa Diagnostics (+11.3%), Kovai Medical Center & Hospital (+10.3%) and Sakar Healthcare (+6.9%).
Show the table and chart
What changed this week (week to 13 November)
- Passing the momentum test (5+ points ahead of the Nifty 500 over 3 months, within 20% of the 52-week high): 10 at the 13 November scan, against 6 at the 6 November scan
- Biggest weekly falls: Healthcare Global Enterprises (-4.5%), Vijaya Diagnostic Centre (-4.0%) and Narayana Hrudayalaya (-2.2%)
- New price breakouts in the week to 13 November: Dr Agarwals Health Care, Dr Agarwals Eye Hospital and Kovai Medical Center & Hospital
- Price breakdowns in the same week: Healthcare Global Enterprises and Vimta Labs
"Passes weekly test" below means a 3-month return at least 5 points above the Nifty 500, a market value of ₹500 crore or more and a price within 20% of the 52-week high, checked at each weekly scan.
| Company | Week | 3M vs Nifty 500 | Passes weekly test | Weeks ahead (of 26) |
|---|---|---|---|---|
| Krsnaa Diagnostics | +11.3% | −8.7 pts | No | 7 |
| Kovai Medical Center & Hospital | +10.3% | +8.1 pts | Yes | 26 |
| Sakar Healthcare | +6.9% | +18.4 pts | Yes | 26 |
| Dr Agarwals Health Care | +6.7% | +8.2 pts | Yes | 24 |
| Vasa Denticity | +5.8% | +15.6 pts | No | 13 |
| Zota Health Care | +5.4% | +14.1 pts | No | 11 |
| Artemis Medicare Services | +5.1% | +1.7 pts | No | 26 |
| Global Health | +4.8% | +1.6 pts | No | 22 |
| 3B Blackbio DX | +4.5% | +13.6 pts | No | 13 |
| Poly Medicure | +4.3% | −6.5 pts | No | 20 |
| Shalby | +4.3% | −19.5 pts | No | 9 |
| Laxmi Dental | +3.9% | +0.5 pts | No | 12 |
| Entero Healthcare Solutions | +3.6% | +38.4 pts | Yes | 18 |
| Yatharth Hospital & Trauma Care Services | +3.3% | +25.0 pts | Yes | 22 |
| Medplus Health Services | +2.4% | −8.0 pts | No | 3 |
| Suraksha Diagnostic | +2.4% | +11.5 pts | Yes | 18 |
| Rainbow Childrens Medicare | +2.2% | −13.6 pts | No | 18 |
| Max Healthcare Institute | +1.4% | −6.7 pts | No | 10 |
| Aster DM Quality Care | +1.3% | −12.7 pts | No | 15 |
| Dr Lal Pathlabs | +1.2% | +3.4 pts | No | 26 |
| Thyrocare Technologies | +1.0% | −20.8 pts | No | 21 |
| Apollo Hospitals Enterprise | +0.9% | −5.0 pts | No | 20 |
| Krishna Institute of Medical Sciences | +0.9% | −10.4 pts | No | 15 |
| Vimta Labs | +0.5% | −19.7 pts | No | 20 |
| Chandan Healthcare | +0.4% | −5.6 pts | No | 6 |
| Indraprastha Medical Corporation | 0.0% | −12.2 pts | No | 0 |
| GPT Healthcare | -0.1% | −8.5 pts | No | 20 |
| Fortis Healthcare | -0.4% | −18.4 pts | No | 10 |
| Tarsons Products | -0.5% | −13.0 pts | No | 24 |
| Metropolis Healthcare | -0.8% | +2.8 pts | No | 22 |
| Jupiter Life Line Hospitals | -1.0% | −10.4 pts | No | 15 |
| Narayana Hrudayalaya | -2.2% | +0.9 pts | No | 15 |
| Vijaya Diagnostic Centre | -4.0% | −4.9 pts | No | 25 |
| Healthcare Global Enterprises | -4.5% | −20.4 pts | No | 20 |
| Park Medi World | −9.8 pts | No | 18 | |
| Nephrocare Health Services | −7.1 pts | No | 21 | |
| KMC Speciality Hospitals | +25.8 pts | Yes | 26 | |
| Dr Agarwals Eye Hospital | +12.1 pts | Yes | 19 | |
| Gujarat Kidney & Super Speciality | +13.5 pts | No | 23 | |
| Health X Platform | −6.4 pts | No | 13 | |
| Sastasundar Ventures | −0.6 pts | No | 8 | |
| Hemant Surgical Industries | +74.3 pts | Yes | 22 | |
| Unihealth Hospitals | −21.5 pts | No | 19 | |
| One Global Service Provider | −33.7 pts | No | 10 | |
| Gaudium IVF and Women Health | −14.5 pts | No | 17 | |
| Prevest Denpro | +8.9 pts | Yes | 9 |
Healthcare stocks beating the Nifty 500, week by week
| Week | Beating the Nifty 500 |
|---|---|
| 18 Sep 2026 | 26 of 45 |
| 25 Sep 2026 | 22 of 46 |
| 1 Oct 2026 | 17 of 46 |
| 9 Oct 2026 | 13 of 46 |
| 16 Oct 2026 | 12 of 46 |
| 23 Oct 2026 | 8 of 46 |
| 30 Oct 2026 | 8 of 46 |
| 6 Nov 2026 | 6 of 46 |
| 13 Nov 2026 | 10 of 46 |
Weekly closes, week to 13 November 2026 against the week to 6 November 2026. Updated every weekend
How to track healthcare stocks every week?
The table at the top works as a free healthcare stock screener for all 46 companies. It has price, P/E, 52-week range and returns against the Nifty 500. Download the CSV to sort and filter the rows in a spreadsheet.
Download all 46 healthcare stocks (CSV) · How the numbers are worked out
Rebuilt every weekend
Questions people ask about healthcare stocks
5 short answers from this page's own numbers, as of the 13 November 2026 scan.
Will healthcare stocks rebound?
It depends on the company. At the 13 November 2026 scan, 10 of 46 healthcare stocks beat the Nifty 500 and 32 of 41 grew earnings per share.
Are healthcare stocks defensive?
It depends on the company. At the 13 November 2026 scan, 10 of 46 healthcare stocks beat the Nifty 500 and 32 of 41 grew earnings per share.
Are healthcare stocks recession proof?
It depends on the company. At the 13 November 2026 scan, 10 of 46 healthcare stocks beat the Nifty 500 and 32 of 41 grew earnings per share.
Are healthcare stocks cyclical?
It depends on the company. At the 13 November 2026 scan, 10 of 46 healthcare stocks beat the Nifty 500 and 32 of 41 grew earnings per share.
Which healthcare stocks will benefit from ai?
It depends on the company. At the 13 November 2026 scan, 10 of 46 healthcare stocks beat the Nifty 500 and 32 of 41 grew earnings per share.
P/E and P/B: one figure per company on this page, at the price shown (20 November 2026), from Screener. Each company's "usual" level is its own long-run median, from our weekly valuation record. For 1 company Screener has no figure, so the record's latest figure is shown.
More lists
All 43 lists across India and US